Research led by the New York State Psychiatric Institute, New York, has looked into non-medical lysergic acid diethylamide (LSD) use by people with major depression status and their ...

LSD-assisted psychotherapy was shown to reduce the anxiety of terminal cancer patients, the drinking of alcoholics, and the symptoms of many difficult-to-treat psychiatric illnesses. For example ...

But these drugs — LSD, mushrooms, and ecstasy, to name a few — are categorized by the federal government as schedule 1 substances, with high risk of abuse and no medical value.

For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering ...

Mind Medicine, which is based in New York City, will launch the first-ever clinical trial on LSD and MDMA in January 2021 to determine if the drug combination is safe for human use. Dr. Matthias ...

1) The idea of using psychedelics for medicine isn't new. The idea of using psychedelic drugs as medicine is not new at all. In 1943, Albert Hofmann serendipitously discovered the effects of LSD ...

Do LSD, MDMA and mushrooms have legitimate promise in medical science? Many researchers now suggest that long-banned psychedelics may have a valuable role to play in human psychology ...

Psychedelics like ketamine and LSD straddle a fine line—offering therapeutic promise under medical supervision, yet posing serious health risks when trafficked through darknet syndicates for personal ...

Although LSD is considered a Schedule 1 drug (substances with no currently accepted medical use and a high potential for abuse) by the U.S. Drug Enforcement Administration, microdosing has been ...

Health Secretary Robert F. Kennedy Jr. and other Trump officials are signaling their interest in approving psychedelic drugs ...

A single oral administration of an LSD-based medicine provided rapid and durable improvement in moderate to severe generalized anxiety disorder (GAD) in a phase 2B study.